iTherX Pharmaceuticals Inc. Report issue

For profit Phase 1
Founded: San Diego CA United States (1992)
Status: Defunct (2015)

Organization Overview

First Clinical Trial
2012
NCT01560468
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2012

Timeline

NOW
  • Now

Active Ingredients

Drugs in Phase 1 Trials (1)

itx 5061 (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Communicable Diseases (Phase 1)

Hepatitis (Phase 1)

Hepatitis A (Phase 1)

Hepatitis C (Phase 1)

Infections (Phase 1)

Overview

  • Highest Phase: Phase 1
  • # of Trials: 1
  • # of Trial APIs: 1